Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1199.12
11.460.96%
At Close: -
$1199.12
00.00%
After Hours: Aug 23, 4:37 PM EDT
15 minutes delayed
Comments
Loading...
Regeneron Pharmaceuticals (REGN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Quotes, Forecast and News Summary
Regeneron Pharmaceuticals Stock (NASDAQ: REGN) stock price, news, charts, stock research, profile.
| Open | $1.20K |
| Close | $1.20K |
| Volume / Avg. | 352.60K / 452.82K |
| Day Range | $1.19K - $1.20K |
| 52 Wk Range | 769.19 - 1.20K |
| Market Cap | $132.18B |
| P/E Ratio | 31.47 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 75 |
| Short Interest | 1.92% |
| Days to Cover | 5.16 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Regeneron Pharmaceuticals, Inc.
Sector
Health Care
Industry
Biotechnology
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, c...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Regeneron Pharmaceuticals (REGN) stock?
You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.
Who are Regeneron Pharmaceuticals (REGN) competitors?
Other companies in Regeneron Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for Regeneron Pharmaceuticals (REGN) stock?
Regeneron Pharmaceuticals has a consensus price target of $1051.79.
What is the current price for Regeneron Pharmaceuticals (REGN)?
The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $1199.12 last updated August 23, 2024 at 4:37 PM EDT.
Does Regeneron Pharmaceuticals (REGN) pay a dividend?
There are no upcoming dividends for Regeneron Pharmaceuticals.
When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?
Regeneron Pharmaceuticals’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Regeneron Pharmaceuticals (REGN) going to split?
There is no upcoming split for Regeneron Pharmaceuticals.
What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?
Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.